Source: ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maysa Alhawmdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson, Mojgan Najafzadeh. Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer. ERJ Open Res, 7 (3) 00555-2020; 10.1183/23120541.00555-2020

Member's Comments

No comment yet.

Related content which might interest you: Are biphosphonates efficient in the adjuvant treatment of lung cancer? Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)? Source: Eur Respir J 2003; 22: Suppl. 45, 64s Year: 2003 Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Systemic therapy. non small cell lung cancer stage I and II: treatment standards and new development Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Immunotherapy (as an adjuvant therapeutic tool) of tuberculosis - does it have a future? Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Precision medicine for lung cancer: new targeted treatments  Source: International Congress 2017 – Precision medicine approaches in lung cancer Year: 2017 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator? Source: ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018 Year: 2018 Innovative local therapies in lung cancer Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Advances in target therapy in lung cancer Source: Eur Respir Rev 2015; 24: 23-29 Year: 2015 Advances in target therapy for lung cancer Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I Year: 2014 Checkpointinhibition in lung cancer – already standard of care in any line of therapy?  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018